Literature DB >> 25264478

Indoleamine 2,3-dioxygenase inhibitors: potential treatment for cancer, sepsis, and more.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2014        PMID： 25264478      PMCID： PMC4173634          DOI： 10.1021/ml5002773

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 - 2012).

Authors:  Eduard Dolušić; Raphaël Frédérick
Journal:  Expert Opin Ther Pat       Date:  2013-08-30       Impact factor: 6.674

Review 2.  Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy.

Authors:  X Liu; R C Newton; S M Friedman; P A Scherle
Journal:  Curr Cancer Drug Targets       Date:  2009-12       Impact factor: 3.428

3.  Turn off the IDO: will clinical trials be successful?

Authors:  Sergey V Novitskiy; Harold L Moses
Journal:  Cancer Discov       Date:  2012-08       Impact factor: 39.397

Review 4.  Blocking IDO activity to enhance anti-tumor immunity.

Authors:  David H Munn
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.